Discover 151 paid clinical trials in Augusta, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 151
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Portland ME, Ottawa, Little Silver NJ, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Training and Implementation of RUBI in Community Mental Health Settings
for
Autism Spectrum Disorder
Location: Augusta ME
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0+
Code: NCT05742464
Recruiting
Nerve Block for Pain Control After Fracture Surgery
for
Ankle Fractures, Distal Radius Fracture
Location: Augusta ME
Sponsor: MaineGeneral Health
Sex: All
Age: 18+
Code: NCT05391464
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Augusta ME, South Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma